{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T16:22:55Z","timestamp":1791562975621,"version":"4.3.4"},"reference-count":80,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T00:00:00Z","timestamp":1726012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Ollier disease (OD), acute myeloid leukemia (AML), and brain glioma (BG) are three apparently completely different neoplasms in terms of histopathology, clinic, natural history, and management, but they can affect the same patient. This study aimed to identify the common molecular pathways involved in the pathogenesis of all three diseases and discuss their current and potential role as therapeutic targets. A detailed and comprehensive systematic literature review according to PRISMA guidelines on OD patients harboring BG and\/or AML was made. In addition, the unique case of a patient affected by all three considered diseases has been added to our case series. Demographic, pathological, treatment, and outcome data were analyzed and discussed, mainly focusing on the molecular findings. Twenty-eight studies reported thirty-three patients affected by OD and BG, and only one study reported one patient with OD and AML, while only our patient harbored all three pathologies. The IDH R132H mutation was the only genetic alteration shared by all three pathologies and was simultaneously detected in enchondromas and brain glioma in 100% (3\/3) of OD patients with BG and also in the neoplastic blood cells of the single patient hosting all three diseases. The IDH1-R132H gene mutation is the etiopathogenetic common denominator among three apparently different tumors coexisting in the same patient. The adoption of mutant-specific IDH1 inhibitor molecules could represent a potential panacea for these conditions in the era of targeted therapies. Further studies with larger clinical series are needed to confirm our results and hypothesis.<\/jats:p>","DOI":"10.3390\/cancers16183125","type":"journal-article","created":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T02:34:49Z","timestamp":1726022089000},"page":"3125","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Ollier Disease, Acute Myeloid Leukemia, and Brain Glioma: IDH as the Common Denominator"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4918-6857","authenticated-orcid":false,"given":"Sergio","family":"Corvino","sequence":"first","affiliation":[{"name":"Department of Neurosciences, Reproductive and Odontostomatological Sciences, Neurosurgical Clinic, School of Medicine, Universit\u00e0 di Napoli \u201cFederico II\u201d, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Somma","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, Reproductive and Odontostomatological Sciences, Neurosurgical Clinic, School of Medicine, Universit\u00e0 di Napoli \u201cFederico II\u201d, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Certo","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, Division of Neurosurgery, Policlinico \u201cG. Rodolico-S. Marco\u201d, University Hospital, 95123 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4749-7929","authenticated-orcid":false,"given":"Giulio","family":"Bonomo","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, Division of Neurosurgery, Policlinico \u201cG. Rodolico-S. Marco\u201d, University Hospital, 95123 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Grasso","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, Division of Neurosurgery, Policlinico \u201cG. Rodolico-S. Marco\u201d, University Hospital, 95123 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1051-5924","authenticated-orcid":false,"given":"Felice","family":"Esposito","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, Reproductive and Odontostomatological Sciences, Neurosurgical Clinic, School of Medicine, Universit\u00e0 di Napoli \u201cFederico II\u201d, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3920-2588","authenticated-orcid":false,"given":"Jacopo","family":"Berardinelli","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, Reproductive and Odontostomatological Sciences, Neurosurgical Clinic, School of Medicine, Universit\u00e0 di Napoli \u201cFederico II\u201d, 80131 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7760-6700","authenticated-orcid":false,"given":"Giuseppe","family":"Barbagallo","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, Division of Neurosurgery, Policlinico \u201cG. Rodolico-S. Marco\u201d, University Hospital, 95123 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,9,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s00381-009-0873-z","article-title":"Ollier disease","volume":"25","author":"Massimi","year":"2009","journal-title":"Childs Nerv. Syst."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1750-1172-1-37","article-title":"Ollier disease","volume":"1","author":"Silve","year":"2006","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"S607","DOI":"10.4103\/2152-7806.189731","article-title":"Ollier disease with anaplastic astrocytoma: A review of the literature and a unique case","volume":"7","author":"Gajavelli","year":"2016","journal-title":"Surg. Neurol. Int."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1634\/theoncologist.2011-0200","article-title":"Incidence, predictive factors, and prognosis of chondrosarcoma in patients with Ollier disease and Maffucci syndrome: An international multicenter study of 161 patients","volume":"16","author":"Verdegaal","year":"2011","journal-title":"Oncologist"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1002\/ajmg.a.61530","article-title":"Natural history of Ollier disease and Maffucci syndrome: Patient survey and review of clinical literature","volume":"182","author":"Robbins","year":"2020","journal-title":"Am. J. Med. Genet. Part A"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/pbc.21050","article-title":"Acute myelogenous leukemia associated with Ollier disease","volume":"50","author":"White","year":"2008","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/1097-0142(19840401)53:7<1605::AID-CNCR2820530731>3.0.CO;2-N","article-title":"Enchondromatosis (Ollier\u2019s disease) and ovarian juvenile granulosa cell tumor","volume":"53","author":"Tamimi","year":"1984","journal-title":"Cancer"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Corvino, S., Mariniello, G., Corazzelli, G., Franca, R.A., Del Basso De Caro, M., Della Monica, R., Chiariotti, L., and Maiuri, F. (2022). Brain Gliomas and Ollier Disease: Molecular Findings as Predictive Risk Factors?. Cancers, 14.","DOI":"10.3390\/cancers14143464"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/S0140-6736(23)00108-3","article-title":"Acute myeloid leukaemia","volume":"401","author":"DiNardo","year":"2023","journal-title":"Lancet"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/ajh.26822","article-title":"Acute myeloid leukemia: 2023 update on diagnosis, risk-stratification, and management","volume":"98","author":"Shimony","year":"2023","journal-title":"Am. J. Hematol."},{"key":"ref_11","unstructured":"(2024, September 01). SEER Data Base: Cancer Stat Facts: Leukemia\u2014Acute Myeloid Leukemia (AML), Available online: https:\/\/seer.cancer.gov\/statfacts\/html\/amyl.html."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO Classification of Tumors of the Central Nervous System: A summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro-Oncology"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/neuonc\/noac207","article-title":"Isocitrate dehydrogenase (IDH) mutant gliomas: A Society for Neuro-Oncology (SNO) consensus review on diagnosis, management, and future directions","volume":"25","author":"Miller","year":"2023","journal-title":"Neuro-Oncology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1093\/neuonc\/noad100","article-title":"Molecular diagnostic tools for the World Health Organization (WHO) 2021 classification of gliomas, glioneuronal and neuronal tumors; an EANO guideline","volume":"25","author":"Sahm","year":"2023","journal-title":"Neuro-Oncology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic\/Dendritic Neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: Integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/BF00389685","article-title":"Dyschondroplasia with glioma of the brain. Third histologically verified case","volume":"93","author":"Becker","year":"1979","journal-title":"Arch. Orthop. Trauma Surg."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1227\/00006123-198709000-00023","article-title":"A case of Ollier\u2019s disease associated with two intracranial gliomas","volume":"21","author":"Rawlings","year":"1987","journal-title":"Neurosurgery"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2106\/00004623-198769020-00016","article-title":"The malignant potential of enchondromatosis","volume":"69","author":"Schwartz","year":"1987","journal-title":"J. Bone Jt. Surg."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/BF00314239","article-title":"Ollier\u2019s disease and Maffucci\u2019s syndrome: Distinct entities or a continuum","volume":"235","author":"Mellon","year":"1988","journal-title":"J. Neurol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1227\/00006123-199009000-00029","article-title":"A case of dyschondroplasia associated with brain stem glioma: Diagnosis by stereotactic biopsy","volume":"27","author":"Patt","year":"1990","journal-title":"Neurosurgery"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0720-048X(91)90115-C","article-title":"Multiple enchondromatosis (Ollier\u2019s disease) complicated by malignant astrocytoma","volume":"12","author":"Bendel","year":"1991","journal-title":"Eur. J. Radiol."},{"key":"ref_24","first-page":"903","article-title":"Identical twins with Ollier\u2019s disease and intracranial gliomas: Case report","volume":"34","author":"Chang","year":"1994","journal-title":"Neurosurgery"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1007\/s002560050460","article-title":"Simultaneous occurrence of a supra- and an infratentorial glioma in a patient with Ollier\u2019s disease: More evidence for non-mesodermal tumor predisposition in multiple enchondromatosis","volume":"27","author":"Hofman","year":"1998","journal-title":"Skelet. Radiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/00041327-199903000-00021","article-title":"Neuro-ophthalmologic manifestations of Maffucci\u2019s syndrome and Ollier\u2019s disease","volume":"19","author":"Balcer","year":"1999","journal-title":"J. Neuro-Ophthalmol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s003810050377","article-title":"Diffuse brain stem tumor in an adolescent with multiple enchondromatosis (Ollier\u2019s disease)","volume":"15","author":"Frappaz","year":"1999","journal-title":"Childs Nerv. Syst."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0303-8467(98)00072-9","article-title":"A case of Ollier\u2019s disease associated with two intracerebral low-grade gliomas","volume":"101","year":"1999","journal-title":"Clin. Neurol. Neurosurg."},{"key":"ref_29","first-page":"66","article-title":"Ollier\u2019s disease with intracranial glioma","volume":"12","author":"Simsek","year":"2002","journal-title":"T\u00fcrk N\u00f6rosir\u00fcrji Derg."},{"key":"ref_30","first-page":"1261","article-title":"Multiple enchondromatosis Ollier\u2019s disease with two primary brain tumors","volume":"25","author":"Mahafza","year":"2004","journal-title":"Saudi Med. J."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/01.wnq.0000214039.38720.b4","article-title":"Ollier Disease Anaplastic Mixed Oligoastrocytoma: A Rare Association with Brain Tumors","volume":"16","author":"Koc","year":"2006","journal-title":"Neurosurg. Q."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3171\/2009.5.PEDS08422","article-title":"Pediatric thalamic glioblastoma associated with Ollier disease (multiple enchondromatosis): A rare case of concurrence","volume":"4","author":"Ranger","year":"2009","journal-title":"J. Neurosurg. Pediatr."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11060-008-9583-8","article-title":"Cerebellar anaplastic astrocytoma in a teenager with Ollier Disease","volume":"89","author":"Walid","year":"2008","journal-title":"J. Neuro-Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"595","DOI":"10.3892\/ol_00000105","article-title":"Diffuse gliomas in an adolescent with multiple enchondromatosis (Ollier\u2019s disease)","volume":"1","author":"Hori","year":"2010","journal-title":"Oncol. Lett."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"58","DOI":"10.4103\/0971-3026.95406","article-title":"Multifocal intracranial astrocytoma in a pediatric patient with Ollier disease","volume":"22","author":"Bathla","year":"2012","journal-title":"Indian J. Radiol. Imaging"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.jocn.2011.06.019","article-title":"Multifocal supratentorial diffuse glioma in a young patient with Ollier disease","volume":"19","author":"Pearce","year":"2012","journal-title":"J. Clin. Neurosci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s40478-016-0302-y","article-title":"Characteristics of gliomas in patients with somatic IDH mosaicism","volume":"4","author":"Bonnet","year":"2016","journal-title":"Acta Neuropathol. Commun."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s10014-017-0303-y","article-title":"Enchondromatosis-associated oligodendroglioma: Case report and literature review","volume":"35","author":"Achiha","year":"2018","journal-title":"Brain Tumor Pathol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"240","DOI":"10.14740\/jnr580","article-title":"Diffuse astrocytoma and Ollier\u2019s Disease","volume":"10","year":"2020","journal-title":"J. Neurol. Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1016\/j.radcr.2021.05.046","article-title":"Diffuse midline glioma in Ollier disease: A case report and a brief review of the literature","volume":"16","author":"Karabulut","year":"2021","journal-title":"Radiol. Case Rep."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e1747","DOI":"10.1212\/WNL.0000000000012269","article-title":"Teaching NeuroImage: Histopathologically Confirmed Intracranial Enchondroma\/Low-Grade Chondrosarcoma and IDH1-Mutated Diffuse Glioma in Ollier Disease","volume":"97","author":"Gregory","year":"2021","journal-title":"Neurology"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/neup.12902","article-title":"Supratentorial multifocal gliomas associated with Ollier disease harboring IDH1 R132H mutation: A case report","volume":"43","author":"Ikeda","year":"2023","journal-title":"Neuropathology"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s11060-017-2676-5","article-title":"Glioblastoma and acute myeloid leukemia: Malignancies with striking similarities","volume":"136","author":"Goethe","year":"2018","journal-title":"J. Neuro-Oncol."},{"key":"ref_44","unstructured":"Louis, D.N., Ohgaki, H., Wiestler, O.D., and Cavenee, W.K. (2016). WHO Classification of Tumours of the Central Nervous System, IARC. [4th ed.]."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","article-title":"Genomic Classification and Prognosis in Acute Myeloid Leukemia","volume":"374","author":"Papaemmanuil","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/path.2913","article-title":"IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours","volume":"224","author":"Amary","year":"2011","journal-title":"J. Pathol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1038\/ng.994","article-title":"Ollier disease and Maffucci syndrome are caused by somatic mosaic mutations of IDH1 and IDH2","volume":"43","author":"Amary","year":"2011","journal-title":"Nat. Genet."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1038\/ng.1004","article-title":"Somatic mosaic IDH1 and IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndrome","volume":"43","author":"Pansuriya","year":"2011","journal-title":"Nat. Genet."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s10014-018-0327-y","article-title":"Molecular profiling of different glioma specimens from an Ollier disease patient suggests a multifocal disease process in the setting of IDH mosaicism","volume":"35","author":"Tan","year":"2018","journal-title":"Brain Tumor Pathol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1136\/jclinpath-2020-206813","article-title":"Gene of the month: IDH1","volume":"73","author":"Govender","year":"2020","journal-title":"J. Clin. Pathol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.molmed.2010.07.002","article-title":"IDH mutations in glioma and acute myeloid leukemia","volume":"16","author":"Dang","year":"2010","journal-title":"Trends Mol. Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/annonc\/mdw013","article-title":"IDH mutations in cancer and progress toward development of targeted therapeutics","volume":"27","author":"Dang","year":"2016","journal-title":"Ann. Oncol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s13045-022-01339-8","article-title":"Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation","volume":"15","author":"Kunadt","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/s41375-022-01751-6","article-title":"Isocitrate dehydrogenase 1 mutation drives leukemogenesis by PDGFRA activation due to insulator disruption in acute myeloid leukemia (AML)","volume":"37","author":"Silva","year":"2023","journal-title":"Leukemia"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Messina, M., Piciocchi, A., Ottone, T., Paolini, S., Papayannidis, C., Lessi, F., Fracchiolla, N.S., Forghieri, F., Candoni, A., and Mengarelli, A. (2022). Prevalence and Prognostic Role of IDH Mutations in Acute Myeloid Leukemia: Results of the GIMEMA AML1516 Protocol. Cancers, 14.","DOI":"10.3390\/cancers14123012"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/s41571-021-00521-0","article-title":"The implications of IDH mutations for cancer development and therapy","volume":"18","author":"Pirozzi","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1056\/NEJMoa0808710","article-title":"IDH1 and IDH2 mutations in gliomas","volume":"360","author":"Yan","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1056\/NEJMoa0903840","article-title":"Recurring mutations found by sequencing an acute myeloid leukemia genome","volume":"361","author":"Mardis","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ccr.2010.11.015","article-title":"Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation","volume":"18","author":"Figueroa","year":"2010","journal-title":"Cancer Cell"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.1200\/JCO.2010.28.3762","article-title":"IDH1 and IDH2 mutations are frequent genetic alterations in acute myeloid leukemia and confer adverse prognosis in cytogenetically normal acute myeloid leukemia with NPM1 mutation without FLT3 internal tandem duplication","volume":"28","author":"Paschka","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1038\/leu.2011.142","article-title":"Prevalence and prognostic value of IDH1 and IDH2 mutations in childhood AML: A study of the AML-BFM and DCOG study groups","volume":"25","author":"Damm","year":"2011","journal-title":"Leukemia"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Chen, C., Li, J., Jiang, T., Tang, J., Zhang, Z., Luo, Y., Wang, X., Sun, K., Jiang, Z., and Zhou, J. (2022). IDH Mutations Are Potentially the Intrinsic Genetic Link among the Multiple Neoplastic Lesions in Ollier Disease and Maffucci Syndrome: A Clinicopathologic Analysis from a Single Institute in Shanghai, China. Diagnostics, 12.","DOI":"10.3390\/diagnostics12112764"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1038\/nchembio.1930","article-title":"New IDH1 mutant inhibitors for treatment of acute myeloid leukemia","volume":"11","author":"Bartholdy","year":"2015","journal-title":"Nat. Chem. Biol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1200\/JCO.19.03327","article-title":"Ivosidenib in Isocitrate Dehydrogenase 1\u2014Mutated Advanced Glioma","volume":"38","author":"Mellinghoff","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1056\/NEJMoa2304194","article-title":"Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma","volume":"389","author":"Mellinghoff","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/s41591-022-02141-2","article-title":"Vorasidenib and ivosidenib in IDH1-mutant low-grade glioma: A randomized, perioperative phase 1 trial","volume":"29","author":"Mellinghoff","year":"2023","journal-title":"Nat. Med."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"E6","DOI":"10.3171\/2014.10.FOCUS12367","article-title":"Survival and low-grade glioma: The emergence of genetic information","volume":"38","author":"Claus","year":"2015","journal-title":"Neurosurg. Focus"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s11060-019-03316-7","article-title":"Observation after surgery for low grade glioma: Long-term outcome in the light of the 2016 WHO classification","volume":"145","author":"Jansen","year":"2019","journal-title":"J. Neuro-Oncol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/cncr.26298","article-title":"IDH1 mutations in grade II astrocytomas are associated with unfavorable progression-free survival and prolonged postrecurrence survival","volume":"118","author":"Thon","year":"2012","journal-title":"Cancer"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.3171\/2013.1.JNS121","article-title":"Spontaneous and therapeutic prognostic factors in adult hemispheric World Health Organization Grade II gliomas: A series of 1097 cases: Clinical article","volume":"118","author":"Capelle","year":"2013","journal-title":"J. Neurosurg."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.ijrobp.2019.08.025","article-title":"Malignant Transformation of Molecularly Classified Adult Low-Grade Glioma","volume":"105","author":"Tom","year":"2019","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.wneu.2016.04.030","article-title":"Progressive Low-Grade Glioma: Assessment of Prognostic Importance of Histologic Reassessment and MRI Findings","volume":"99","author":"Narang","year":"2017","journal-title":"World Neurosurg."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10143-015-0675-6","article-title":"Incidental diffuse low-grade gliomas: From early detection to preventive neuro-oncological surgery","volume":"39","author":"Lima","year":"2016","journal-title":"Neurosurg. Rev."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00701-015-2621-3","article-title":"Long-term outcomes after supratotal resection of diffuse low-grade gliomas: A consecutive series with 11-year follow-up","volume":"158","author":"Duffau","year":"2016","journal-title":"Acta Neurochir."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2176\/jns-nmc.2021-0313","article-title":"Malignant Progression of Diffuse Low-grade Gliomas: A Systematic Review and Meta-analysis on Incidence and Related Factors","volume":"62","author":"Nakasu","year":"2022","journal-title":"Neurol. Med. Chir."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"vdab101","DOI":"10.1093\/noajnl\/vdab101","article-title":"Systematic review-Time to malignant transformation in low-grade gliomas: Predicting a catastrophic event with clinical, neuroimaging, and molecular markers","volume":"3","author":"Satar","year":"2021","journal-title":"Neuro-Oncol. Adv."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Cesselli, D., Ius, T., Isola, M., Del Ben, F., Da Col, G., Bulfoni, M., Turetta, M., Pegolo, E., Marzinotto, S., and Scott, C.A. (2019). Application of an Artificial Intelligence Algorithm to Prognostically Stratify Grade II Gliomas. Cancers, 12.","DOI":"10.3390\/cancers12010050"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3171\/2008.10.JNS08608","article-title":"Recurrence and malignant degeneration after resection of adult hemispheric low-grade gliomas","volume":"112","author":"Chaichana","year":"2010","journal-title":"J. Neurosurg."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0140-6736(05)67070-5","article-title":"Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: The EORTC 22845 randomised trial","volume":"366","author":"Afra","year":"2005","journal-title":"Lancet"},{"key":"ref_80","first-page":"CD009319","article-title":"Biopsy versus resection for the management of low-grade gliomas","volume":"4","author":"Veeravagu","year":"2013","journal-title":"Cochrane Database Syst. Rev."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/16\/18\/3125\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:53:26Z","timestamp":1760111606000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/16\/18\/3125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,11]]},"references-count":80,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["cancers16183125"],"URL":"https:\/\/doi.org\/10.3390\/cancers16183125","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,11]]}}}